SCHIZOPHRENIA 1 (Disorder)
31
7
7
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 31 trials
100.0%
+13.4% vs benchmark
3%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (31)
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Brain Imaging of DSP-2342
Building a Computational Model of Auditory Hallucinations
Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers
Multi-target TMS for Schizophrenia Negative Symptoms
Disorders of the Sense of Self and Physical Activity
Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
Simulation-Based Schizophrenia Training in Nursing Education
Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia
Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia
TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine)
Online Intervention To Improve Motivation
The Effect of ACT-Based Nursing Interventions on Social Cognition, Emotion Regulation and Psychological Flexibility in Patients With Schizophrenia
ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia
Cognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility Study
Precision HD-tACS for Enhancing Sensory Experience in Schizophrenia
Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis